Results 91 to 100 of about 4,213 (222)

Malignant Rhabdoid Tumors of Cranial Nerves—A Clinically Distinct Group With Characteristic Neuroradiological, Histopathological, and Molecular Features

open access: yesPediatric Blood &Cancer, Volume 72, Issue 8, August 2025.
ABSTRACT Background Malignant rhabdoid tumors occasionally develop along cranial nerves, but clinical, histopathological, and molecular features have not been examined in larger series. Procedure We retrospectively interrogated data from the European Rhabdoid Registry, EU‐RHAB, to identify malignant rhabdoid tumors affecting cranial nerves.
Miriam Gruhle   +15 more
wiley   +1 more source

Low back pain with axillary mass in a perimenopausal woman: A case of schwannomatosis mimicking metastasis

open access: yesRadiology Case Reports
Schwannomatosis is a rare neurocutaneous syndrome characterized by the presence of multiple schwannomas along the peripheral nerves, distinctly excluding the vestibular nerves.
Abhikanta Khatiwada   +4 more
doaj   +1 more source

LZTR1 molecular genetic overlap with clinical implications for Noonan syndrome and schwannomatosis

open access: yesBMC Medical Genomics, 2022
Background Noonan syndrome (NS) is a genetic disorder characterized by developmental delays, typical facial gestalt and cardiovascular defects. LZTR1 variants have been recently described in patients with NS and schwannomatosis, but the association ...
Kirsten M. Farncombe   +4 more
doaj   +1 more source

Fatal Tension Hemothorax Combined with Exanguination: A Rare Complication of Neurofibromatosis [PDF]

open access: yes, 2019
Neurofibromatosis (NF) is a common autosomal dominant disorder that can be subdivided into type 1, type 2, and schwannomatosis. Patients with NF1 typically develop café-au-lait spots, scoliosis, and benign neurofibromas.
Bidad, Roz, Blohm, Eike, Hall, Caroline
core  

TANC1::HTRA1 fusion in schwannomas

open access: yes
Brain Pathology, EarlyView.
Ilay Caliskan   +3 more
wiley   +1 more source

Quality of Life Outcomes in Vestibular Schwannoma: A Prospective Analysis of Treatment Modalities

open access: yesThe Laryngoscope, Volume 135, Issue 7, Page 2529-2537, July 2025.
One of the first prospective cohort studies looks at quality of life (QOL) outcomes for the three main treatment modalities for vestibular schwannoma. In our study, we found comparable long‐term disease‐specific QOL outcomes, which will allow clinicians to more accurately counsel patients before making life‐changing treatment decisions.
A. Hotchkies   +14 more
wiley   +1 more source

Primary Coenzyme Q10 Deficiency [PDF]

open access: yes, 2017
open4siCLINICAL CHARACTERISTICS: Primary coenzyme Q10 (CoQ10) deficiency is usually associated with multisystem involvement, including neurologic manifestations such as fatal neonatal encephalopathy with hypotonia; a late-onset slowly progressive ...
Doimo, Mara   +3 more
core  

Genetic Alterations in Patients with NF2-Related Schwannomatosis and Sporadic Vestibular Schwannomas. [PDF]

open access: yesCancers (Basel)
Simple Summary Vestibular schwannomas are tumors that occur on the nerve responsible for hearing and balance, the vestibulocochlear nerve. These benign tumors may appear on one side (unilateral) or both sides (bilateral), with bilateral cases often ...
Douwes JPJ   +5 more
europepmc   +2 more sources

NF2 is Essential for Human Endoderm Development

open access: yesAdvanced Science, Volume 12, Issue 17, May 8, 2025.
This study demonstrates that NF2, moesin‐ezrin‐radixin like (MERLIN) tumor suppressor (NF2) is essential for human endoderm formation. NF2 knockout human induced pluripotent stem cells fail to form endoderm both in vitro and in vivo due to yes‐associated protein 1 (YAP1) nuclear translocation, redirecting differentiation toward myofibroblast‐like cells.
Minjin Jeong   +5 more
wiley   +1 more source

22q11.2 deletion syndrome [PDF]

open access: yes, 2015
22q11.2 deletion syndrome (22q11.2DS) is the most common chromosomal microdeletion disorder, estimated to result mainly from de novo non-homologous meiotic recombination events occurring in approximately 1 in every 1,000 fetuses. The first description in
Bassett, Anne S.   +11 more
core   +1 more source

Home - About - Disclaimer - Privacy